Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration

Journal of Clinical Investigation

Volumn 96, Issue 2, 1995, Pages 1042-1052

  Kapadia, Samir ^b   Lee, Joseph ^b   Torre Amione, Guillermo ^b   Birdsall, Holly H ^b   Ma, Tony S ^b   Mann, Douglas L ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

endotoxin; gene expression; myocyte; TNF

Indexed keywords

COMPLEMENTARY DNA; ENDOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GENE EXPRESSION REGULATION; HEART MUSCLE METABOLISM; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TISSUE DISTRIBUTION;

EID: 0028982826     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118090     Document Type: Article

References (53)

1. Pfeiffer, R. 1892. Untersuchunger uber das Cholera gift. Zeitschrift. Hyg. Infektionskran. 11:393-412.
2. Gulick, T. S., M. K. Chung, S. J. Pieper, L. G. Lange, and G. F. Schreiner. 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc. Natl. Acad. Sci. USA. 86:6753-6757.
3. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (Wash. DC). 257:387-389.
4. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.). 330:662-664.
5. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, and G. T. Shires. 1986. Shock and tissue injury induced by recombinant human cachectin. Science (Wash. DC). 234:470-474.
6. Lefer, A. M. 1970. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed. Proc. 29:1836-1847.
7. Parrillo, J. E., C. Burch, J. H. Shelhamer, M. M. Parker, C. Nathanson, and W. Schuette. 1985. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulation factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76:1539-1553.
8. Lange, L. G., and G. F. Schreiner. 1994. Immune mechanisms of cardiac disease. N. Engl. J. Med. 330:1129-1135.
9. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
10. Parker, M. M., J. H. Shelhamer, S. L. Bacharach, M. V. Green, C. Natanson, T. M. Frederick, B. A. Damske, and J. E. Parrillo. 1984. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100:483-490.
11. Hung, J., and W. Y. W. Lew. 1993. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ. Res. 73:125-134.
12. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. W. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
13. Yokoyama, T., L. Vaca, R. D. Rossen, W. Durante, P. Hazarika, and D. L. Mann. 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J. Clin. Invest. 92:2303-2312.
14. de Groote, M. A., M. A. Martin, P. Densen, M. A. Pfaller, and R. P. Wenzel. 1989. Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. JAMA 262:249-251.
15. Calandra, T., J.-D. Baumgartner, G. E. Grau, M.-M. Wu, P.-H. Lambert, J. Schellekens, J. Verhoef, and M. P. Glauser. 1990. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-gamma in the serum of patients with septic shock. J. Infect. Dis. 161:982-987.
16. Natanson, C., P. W. Eichenholz, R. L. Danner, W. Eichacker, D. Hoffman, S. M. Kuo, T. J. Banks, T. J. MacViottie, and J. E. Parrillo. 1992. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:823-832.
17. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. 1989. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280-287.
18. Ulich, T. R., K. Guo, and J. del Castillo. 1989. Endotoxin-induced cytokine gene expression in vivo. Am. J. Pathol. 134:11-14.
19. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
20. Giroir, B. P., J. H. Johnson, T. Brown, G. L. Allen, and B. Beutler. 1992. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90:693-698.
21. Tanaka, N., T. Kita, K. Kasai, and T. Nagano. 1994. The immunocyto-chemical localization of tumor necrosis factor and leukotriene in the rat heart and lung during endotoxin shock. Virchows Arch. (A)424:273-277.
22. Kita, T., N. Tanaka, and T. Nagano. 1993. The immunolocalization of tumor necrosis factor and leukotrienes in the rat kidney after treatment with lipopolysaccharide. Int. J. Exp. Pathol. 74:471-479.
23. Nagano, T., T. Kita, and N. Tanaka. 1992. The immunocytochemical localization of tumor necrosis factor and leukotriene in the rat liver after treatment with lipopolysaccharide. Int. J. Exp. Pathol. 73:675-683.
24. Mann, D. L., R. L. Kent, and G. Cooper. 1989. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ. Res. 64:1079-1090.
25. Mann, D. L., R. L. Kent, B. Parsons, and G. Cooper. 1992. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:790-804.
26. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulvevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science (Wash. DC). 249:1429-1431.
27. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
28. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:7313-7316.
29. Huang, E. H., C. J. Morgan, D. D. Sedmak, R. M. Ferguson, and C. G. Orosz. 1994. Alloantigenicity in human endothelial cells. Transplantation (Baltimore). 57:703-711.
30. Mann, D. L., Y. Urabe, R. L. Kent, S. Vinciguerra, and G. Cooper. 1991. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. Circ. Res. 68:402-415.
31. Pizarro, T. T., K. Malinowska, E. J. Kovacs, S. Clancy, J. A. Robinson, and L. A. Piccinini. 1993. Induction of TNF-alpha and TNF-beta gene expression in rat cardiac transplants during allograft rejection. Transplantation (Baltimore). 56:399-404.
32. Torre-Amione, G., S. Kapadia, J. Lee, R. D. Bies, R. Lebovitz, and D. L. Mann. 1995. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. In press.
33. Bucana, C. D., R. Radinsky, Z. Dong, R. Sanchez, D. J. Brigati, and I. J. Fidler. 1994. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdrl in mouse colon carcinoma cells. J. Histochem. Cytochem. 41:499-506.
34. Iezzoni, J., J. H. Kang, C. D. Bucana, J. A. Reed, and D. J. Brigati. 1993. Rapid colorimetric detection of epidermal growth factor receptor mRNA by in situ hybridization. J. Clin. Lab. Anal. 7:247-251.
35. Ulich, T. R., K. Guo, B. Irwin, D. G. Remick, and G. N. Davatelis. 1990. Endotoxin-induced cytokine gene expression in vivo. Am. J. Pathol. 137:1173-1185.
36. Ma, T. S., P. A. Brink, B. Perryman, and R. Roberts. 1994. Improved quantification with validation of multiple mRNA species by polymerase chain reaction: application to human myocardial creatine kinase M and B. Cardiovasc. Res. 28:464-471.
37. Kapadia, S., G. Torre-Amione, T. Yokoyama, and D. L. Mann. 1995. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro. Am. J. Physiol. 37:H517-H525.
38. Kriegler, M., C. Perez, K. Defay, I. Albert, and S. D. Lu. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 53:45-53.
39. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 83:1670-1674.
40. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:659-667.
41. Friedman, G., R. Gallily, T. Chajek-Shaul, O. Stein, E. Shiloni, J. Etienne, and Y. Stein. 1988. Lipoprotein lipase in heart cell cultures is suppressed by lipopolysaccharide: an effect mediated by production of tumor necrosis factor. Biochim. Biophys. Acta. 960:220-228.
42. Giroir, B. P., J. W. Norton, J. D. White, K. L. McIntyre, and C. Q. Lin. 1994. Inhibition of tumor necrosis factor prevents myocardial dysfunction during bum shock. Am. J. Physiol. 267:H118-H124.
43. Cooper, G., R. L. Kent, and D. L. Mann. 1989. Load induction of cardiac hypertrophy. J. Mol. Cell. Cardiol. 21(Suppl. V):11-30.
44. Hesse, D. G., K. J. Tracey, Y. Fong, K. R. Manogue, M. A. Palladino, A. Cerami, T. Shires, and S. F. Lowry. 1988. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166:147-153.
45. Hunt, J. S., H. L. Chen, X. L. Hu, T. Y. Chen, and D. C. Morrison. 1992. Tumor necrosis factor-α gene expression in the tissues of normal mice. Cytokine. 4:340-346.
46. Tovey, M. G. 1989. Expression of the genes of interferons and other cytokines in normal and diseased tissues of man. Experientia. 45:526-534.
47. Tovey, M. G., J. Content, I. Gresser, J. Gugenheim, B. Blanchard, J. Guymarho, P. Poupart, M. Gigou, A. Shaw, and W. Fiers. 1988. Genes for IFN-β-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J. Immunol. 141:3106-3110.
48. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-854.
49. Youker, K., C. W. Smith, D. C. Anderson, D. Miller, L. H. Michael, R. D. Rossen, and M. L. Entman. 1992. Neutrophil adherence to isolated adult cardiac myocytes: induction by cardiac lymph collected during ischemia and reperfusion. J. Clin. Invest. 89:602-609.
50. Tsujimoto, M., S. Yokota, J. Vilcek, and G. Weissmann. 1986. Tumor necrosis factor provokes Superoxide anion generation from neutrophils. Biochem. Biophys. Res. Commun. 137:1094-1100.
51. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105:575-580.
52. Nakano, M., A. A. Knowlton, D. Lee-Jackson, and D. L. Mann. 1994. Tumor necrosis factor-α protects against hypoxic injury in adult cardiac myocytes: the role of heat shock protein 70. Circulation. 90:I-467. (Abstr.)
53. Nakata, T., K. Suzuki, J. Fujii, M. Ishikawa, and N. Taniguchi. 1993. Induction and release of manganese superoxide dismutase from mitochondria of human umbilical vein endothelial cells by tumor necrosis factor-alpha and interleukin-1 alpha. Int. J. Cancer. 55:646-650.